| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2443.23 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2965.41 | 99 |
| GSM780709 | Untreated after 4 days (C3_1) | 3243.08 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 2855.67 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2979.88 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 3183.57 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 3173.43 | 99 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 3063.84 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2762.85 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 3034.69 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3089.75 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2450.1 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2978.35 | 99 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2930.81 | 99 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2866.55 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2858.84 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 3072.9 | 99 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2777.13 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2508.83 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2769.67 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2992.99 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2777.13 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2947.95 | 99 |